The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence is taking over drug development,” claim some companies and researchers. Over the past few years, interest in using AI to design drugs and optimise clinical trials has driven a surge in research and investment. AI-driven platforms like AlphaFold, which won the 2024 Nobel Prize for its ability to predict the structure of proteins and design new ones, showcase AI’s potential to accelerate drug development. AI in drug discovery is “nonsense,” warn some industry veterans.…

This story continues at The Next Web

The NBA is experimenting with a digital brain for basketballs. The system is the brainchild of SportIQ, a Finnish startup that develops smart basketballs. Inside each ball’s valve, SportIQ embeds a sensor that tracks a player’s shots. Data is first extracted on their form, position, angle, power, and technique. Next, the information is fed to a mobile app for AI analysis. Players then receive direct feedback and advice. According to SportIQ, over 20 million shots have already been tracked. The company estimates that regular users improve their shooting accuracy by 12%. The results impressed bigwigs at the NBA. They revealed…

This story continues at The Next Web

Deepfakes – essentially putting words in someone else’s mouth in a very believable way – are becoming more sophisticated by the day and increasingly hard to spot. Recent examples of deepfakes include Taylor Swift nude images, an audio recording of President Joe Biden telling New Hampshire residents not to vote, and a video of Ukrainian President Volodymyr Zelenskyy calling on his troops to lay down their arms. Although companies have created detectors to help spot deepfakes, studies have found that biases in the data used to train these tools can lead to certain demographic groups being unfairly targeted. A deepfake…

This story continues at The Next Web

Wearable devices have become a big part of modern health care, helping track a patient’s heart rate, stress levels and brain activity. These devices rely on electrodes, sensors that touch the skin to pick up electrical signals from the body. Creating these electrodes isn’t as easy as it might seem. Human skin is complex. Its properties, such as how well it conducts electricity, can change depending on how hydrated it is, how old you are or even the weather. These changes can make it hard to test how well a wearable device works. Additionally, testing electrodes often involves human volunteers,…

This story continues at The Next Web

As China’s DeepSeek threatens to dismantle Silicon Valley’s AI monopoly, a European alliance has emerged with an alternative to tech’s global order. They call their project OpenEuroLLM. Like DeepSeek, they aim to develop next-generation open-source language models — but their agenda is very different. Their mission: forging European AI that will foster digital leaders and impactful public services across the continent. To support these objectives, OpenEuroLLM is building a family of high-performing, multilingual large language foundation models. The models will be available for commercial, industrial, and public services. Over 20 leading European research institutions, companies, and high-performance computing (HPC) centres…

This story continues at The Next Web